Fachbücher

 

Beiträge in Fachzeitschriften und Fachbüchern

2011

  • Weber-Schoendorfer C, Fritzsche J, Schaefer C. Pregnancy outcomes in women exposed to adalimumab or infliximab. The Experience of the Berlin Institute for Clinical Teratology and Drug Risk Assessment in Pregnancy (Abstract). Reprod Toxicol 2011; 31: 267-8.
  • Hoeltzenbein M, Supcun-Ritzler S, Langthaler M, Daumer-Haas C, Schaefer C. Lacosamide during pregnancy: Experience of the Berlin Institute for Clinical Teratology and Drug Risk Assessment in Pregnancy (Abstract). Reprod Toxicol 2011; 31: 259.
  • Oppermann M, Padberg S, Schaefer C. Angiotensin II-receptor 1-antagonists during 2nd or 3rd trimester: Evaluation of a case series from the Berlin Institute for Clinical Teratology and Drug Risk Assessment in Pregnancy (Abstract). Reprod Toxicol 2011; 31: 264.
  • Hultzsch S, Weber-Schoendorfer, Schaefer C. Pregnancy outcomes after exposure to etanercept (Abstract). Reprod Toxicol 2011; 31: 260.
  • Fritzsche J, Mury D, Wintgens KF Pilch A, Schaefer C, Weber-Schoendorfer C. Infliximab and adalimumab use during lactation (Abstract). Reprod Toxicol 2011; 31: 258.
  • Schaefer C. Drug Safety in Pregnancy – Utopia or achievable prospect? Risk information, risk research, advocacy in Teratology Information Services. Congenit Anom 2011 DOI: 10.1111/j.1741-4520.2010.00308.x
  • Schaefer C, Wieacker P. Teratogene Faktoren. In Murken J, Grimm T, Holinski-Feder (Hrg): Humangenetik, 8. Aufl. Thieme-Verlag 2011 (im Druck).
  • Kranke P, Frambach T, Schelling Ph, Wirbelauer J, Schaefer C, Stamer U. Stillen nach Narkosen: Ist eine Stillpause obligat? AINS 2011; 46: 304-11.
  • Schaefer C, Sartane und ACE-Hemmer schaden dem Feten, Frauenarzt 2011; 52:2-3.
  • Regitz-Zagrosek V, Seeland U, Geibel-Zehender A, Gohlke-Bärwolf C, Kruck I, Schaefer C. Herz-Kreislauf-Erkrankungen in der Schwangerschaft. Dtsch Ärztebl 2011;108:267-73.

2010

  • Hoeltzenbein M, Elefant E, Garayt C, Ornoy A, Clementi M, Manakova E, Merlob P, Rodríguez-Pinilla E,  Rothuizen L, Smorlesi C, te Winkel B, de Santis M, Stephens S, Vial T, Weber-Schoendorfer C, Schaefer C. Maternal exposure to mycophenolate mofetil in pregnancy – Results of the ENTIS collaborative study (Abstract). Reprod Toxicol 2010; 30: 228
  • Habermann F, Karbaum F, Meister R, Weber-Schoendorfer C, Schaefer C. Pregnancy outcome after exposure to second-generation antipsychotics (Abstract). Reprod Toxicol 2010; 30: 228.
  • Fritzsche J, Borisch C, Weber-Schoendorfer C, Schaefer C. High levels of chromium and cobalt in a pregnant patient with metal-on-metal hip arthroplasty (Abstract). Reprod Toxicol 2010; 30: 237-8.
  • Dostal M, Felberg M, Weber-Schoendorfer C, Schaefer C. Treatment of restless legs syndrome during pregnancy (Abstract). Reprod Toxicol 2010;30:236-7.
  • Schaefer C , Fritzsche J, Karbaum  F, Allignol A, Meister R, Weber-Schoendorfer C. 2009 H1N1 Vaccination in Pregnancy – Experience of the European Network of Teratology Information Services (ENTIS) (Abstract). Reprod Toxicol 2010; 30: 220.
  • Rohde A, Schaefer C. Psychopharmakotherapie und psychiatrische Begleitung in Schwangerschaft und Stillzeit. In: Möller, Laux, Kapfhammer (Hrg.): Psychiatrie und Psychotherapie, 4. Aufl. Springer, Heidelberg 2010.
  • Schaefer C. Risiken der Sartantherapie in der Schwangerschaft. Monatsschr Kinderheilk 2010; 12: 5.
  • Hoyer AC, Henrich W, Schaefer C, Spors B, Czernik C. Coumarin Embryopathy after intrauterine exposure to Vitamin K antagonists within the first 10 post-menstrual weeks. Ultraschall in Med 2010; 31: 411–413
  • Hoeltzenbein M, Weber-Schoendorfer C, Padberg S, Borisch C, Schaefer C. Paternal exposure to azathioprine/6-mercaptopurine - Experience of Berlin TIS (Abstract). Reprod Toxicol 2010; 30: 238-9. Poster präsentiert auf der ENTIS-Konferenz 2010 in Barcelona.
  • Rabe T, Ludwig M, Goeckenjan M, Schaefer C. Was bei Langzeitkontrazeption post partum zu beachten ist. Gyne 2010; 1: 19-22.
  • Schaefer C, Meister R, Weber-Schoendorfer C. Isotretinoin exposure and pregnancy outcome- an observational study of the Berlin Institute for Clinical teratology and Drug Risk Assessment in Pregnancy. Arch Gynecol Obstet 2010; 281: 221-7.
  • Henze T, Janzen R, Schumm F, Melms A, Sieb J, Köhler W, Heidenreich F, Tackenberg B, Weber-Schöndorfer C. Immuntherapie bei Myasthenia gravis und Lambert-Eaton Syndrom. Teil 1: Medikamentöse Immunsuppression. Akt Neurol 2010;37 (10):505-517.
  • Nickerson ML, Kostiha BN, Brandt W, Fredericks W, Xu KP, Yu FS, Gold B, Chodosh J, Goldberg M, Lu da W, Yamada M, Tervo TM, Grutzmacher R, Croasdale C, Hoeltzenbein M, Sutphin J, Malkowicz SB, Wessjohann L, Kruth HS, Dean M, Weiss JS. UBIAD1 mutation alters a mitochondrial prenyltransferase to cause Schnyder corneal dystrophy. PLoS One. 2010 May 21;5(5):e10760.
  • Chen W, Ullmann R, Langnick C, Menzel C, Wotschofsky Z, Hu H, Döring A, Hu Y, Kang H, Tzschach A, Hoeltzenbein M, Neitzel H, Markus S, Wiedersberg E, Kistner G, van Ravenswaaij-Arts CM, Kleefstra T, Kalscheuer VM, Ropers HH. Breakpoint analysis of balanced chromosome rearrangements by next-generation paired-end sequencing. Eur J Hum Genet. 2010; 18: 539-43.

2009

  • Rabe T, Ludwig M, Goeckenjan M, Schaefer C. Methoden der Kontrazeption im Wochenbett und Anwendungseinschränkungen bei stillenden Frauen. Gyne 2009; 12: 19-23.
  • Schaefer C, Rohde A. So wenig wie möglich, soviel wie nötig. ÄP Neurologie Psychiatrie 2009; 11: 24-7.
  • Weber-Schoendorfer C, Schaefer C. Multiple Sclerosis, immunomodulators and pregnancy outcome. A prospective observational study. Mult Scler 2009 15:1037-42.
  • Schaefer C, Meister R, Wentzeck R, Weber-Schoendorfer C. Fetal outcome after technetium scintigraphy in early pregnancy. Reprod Toxicol 2009; 28: 161-166.
  • Schaefer C, Weber-Schoendorfer C. Pharmakotherapie in der Schwangerschaft, CME Weiterbildung. Internist 2009; 50: 455-66.
  • Becker C, Stichtenoth D, Wichmann M, Schaefer C, Szinicz L. Blood donors on medication. An approach to minimize drug burden for recipients of blood products and to limit deferral of donors. Transfus Med Hemother 2009; 36: 107-13.
  • Hoeltzenbein M, Weber-Schoendorfer C, Schaefer C. Mycophenolate mofetil – a teratogenic drug? Experience of the Berlin Institute of Clinical teratology and drug risk assessment during pregnancy (Abstract). Medizinische Genetik 2009; 21: 78-9.
  • Schaefer C. Topische und systemische Therapie in der Schwangerschaft (Abstract). JDDG 2009; 7 (Suppl. 4): 43.
  • Jürgens T, Schaefer C, May A. Treatment of cluster headache in pregnancy and lactation. Cephalalgia 2009; 29:391-400.
  • Schaefer C. Arzneimittel in der Schwangerschaft und Stillperiode. In: Reiss M (Hrg): Facharztwissen HNO. Springer, Heidelberg 2009.
  • Schaefer C. Arzneitherapie in Schwangerschaft und Stillzeit. In Arzneimittelkommission der deutschen Ärzteschaft (Hrg): Arzneiverordnungen, 22. Aufl. MMI, Neu-Isenburg 2009.
  • Rabe T, Ludwig M, Goeckenjan M, Schaefer C. Welche Verhütung ist im Anschluss an eine Geburt und in der Stillzeit effektiv? Gyne 2009; 8: 19-21.
  • Gueneau L, Bertrand AT, Jais JP, Salih MA, Stojkovic T, Wehnert M, Hoeltzenbein M, Spuler S, Saitoh S, Verschueren A, Tranchant C, Beuvin M, Lacene E, Romero NB, Heath S, Zelenika D, Voit T, Eymard B, Ben Yaou R, Bonne G. Mutations of the FHL1 gene cause Emery-Dreifuss muscular dystrophy. Am J Hum Genet. 2009 Sep;85(3):338-53.
  • Neumann TE, Allanson J, Kavamura I, Kerr B, Neri G, Noonan J, Cordeddu V, Gibson K, Tzschach A, Krüger G, Hoeltzenbein M, Goecke TO, Kehl HG, Albrecht B, Luczak K, Sasiadek MM, Musante L, Laurie R, Peters H, Tartaglia M, Zenker M, Kalscheuer V. Multiple giant cell lesions in patients with Noonan syndrome and cardio-facio-cutaneous syndrome. Eur J Hum Genet. 2009 Apr;17(4):420-5.
  • Tzschach A, Ramel C, Kron A, Seipel B, Wüster C, Cordes U, Liehr T, Hoeltzenbein M, Menzel C, Ropers HH, Ullmann R, Kalscheuer V, Decker J, Steinberger D. Hypergonadotropic hypogonadism in a patient with inv ins (2;4). Int J Androl. 2009 Jun;32(3):226-30.

2008

  • Weber-Schoendorfer C, Hannemann D, Meister R, Eléfant E, Cuppers-Maarschalkerweerd B, Arnon J, Vial T, Rodriguez-Pinilla E, Clementi M, Robert-Gnansia E, De Santis M, Malm H, Dolivo A, Schaefer C. The safety of calcium channel blockers during pregnancy. A prospective, multicenter, observational study. Reprod Toxicol 2008; 26: 24-30. 
  • Schaefer C, Ornoy A, Clementi M, Meister R, Weber-Schoendorfer C. Using observational cohort data for studying drug effects on pregnancy outcome - Methodological considerations. Reprod Toxicol 2008; 26: 36-41.
  • Meister R, Schaefer C. Statistical methods for estimating the probability of spontaneous abortion in observational studies. – Analyzing pregnancies exposed to coumarin derivatives. Reprod Toxicol 2008; 26: 31-35.
  • Weber-Schoendorfer C, Schaefer C. The safety of cetirizine during pregnancy. A prospective observational cohort study. Reprod Toxicol 2008; 26: 19-23.
  • Diav-Citrin O, Shechtman S, Weinbaum D, Wajnberg R, Avgil M, Arnon J, Di Gianantonio E, Clementi M, Weber-Schoendorfer C, Schaefer C & Ornoy A. Paroxetine and Fluoxetine in Pregnancy: a prospective, multi-center, controlled, observational study. Br J Clin Pharmacol 2008; 65: 695-705.
  • Rohde A, Schaefer C. Betreuung schwangerer und stillender Patientinnen – Psychopharmakotherapie und psychiatrische Begleitung. In: Möller, Laux, Kapfhammer (Hrg.): Psychiatrie und Psychotherapie, 3. Aufl. S. 1235-44. Springer, Heidelberg 2008.
  • Weber-Schoendorfer C, Schaefer C. [Trastuzumab in pregnancy] Letter to the Editor. Reprod Toxicol 2008; 25: 390-1.
  • Panchaud A, Stahl B, Schaefer C, Berlin M, De Santis M, Vial T, Ieri A, Malm H, Eleftheriou G, Buclin T. Topical retinoids exposure during the first trimester of pregnancy (Abstract). Posterpräsentation. World Conference on Clinical Pharmacology and Therapeutics. Quebec, Canada 2008.
  • Schaefer C. 50 Jahre nach Contergan - Eine Betrachtung zur Arzneimittelsicherheit in der Schwangerschaft heute. Arzneiverordnung in der Praxis 2008; 35: 65-6.
  • Hoeltzenbein M, Weber-Schoendorfer C, von Stackelberg L, Schaefer C. Paternal exposure to drugs – Is there an increased risk for congenital abnormalities? Experience of the Berlin Institute of Clinical Teratology and Drug Risk Assessment during Pregnancy (Abstract). Med Genetik 2008; 20: 166.
  • Rabe T, Ludwig M, Bitzer J, Geisthövel F, Schaefer C. Schwangerschaften unter verschiedenen kontrazeptiven Methoden. J Reproduktionsmed Endokrinol 2008; 5: 138-146.
  • Rabe T, Ludwig M, Bitzer J, Geisthövel F, Schaefer C. Terato- bzw. Mutagenität von Arzneimitteln: Wenn unter Anwendung von Kontrazeptiva eine Schwangerschaft eintritt (zertifizierte Fortbildung). Gyne 2008; 5: 1-8.
  • Padberg S, Weber-Schoendorfer C, Schaefer C. Lamotrigine during lactation (Abstract). Reprod Toxicol 2008; 26: 70/71.
  • Weber-Schoendorfer C, Schaefer C. Monoclonal antibody therapy during pregnancy – Experience of the Berlin Teratology Information Service (Abstract). Reprod Toxicol 2008; 26: 75.
  • Weber-Schoendorfer C, Schaefer C. Multiple sclerosis – effects of immunomodulatory therapy on pregnancy outcome: An observational study of the Teratology Information Service Berlin, Germany (Abstract). Birth Def Res A 2008; 82: 298.
  • Hoeltzenbein M, Weber-Schoendorfer C, v. Stackelberg L, Schaefer C. Paternal exposure to drugs – Is there an increased risk for congenital abnormalities? Experience of the Berlin Institute for Clinical Teratology and Drug Risk Assessment during Pregnancy (Abstract). Reprod Toxicol 2008; 26: 64.
  • Møller RS, Kübart S, Hoeltzenbein M, Heye B, Vogel I, Hansen CP, Menzel C, Ullmann R, Tommerup N, Ropers HH, Tümer Z, Kalscheuer VM. Truncation of the Down syndrome candidate gene DYRK1A in two unrelated patients with microcephaly. Am J Hum Genet. 2008 May;82(5):1165-70.

2007

  • Goldstein LH, Dolinsky G, Greenberg R, Schaefer C, Cohen-Kerem R, Diav-Citrin  O, Malm H, Reuvers-Lodewijks ME, Rost van Tonningen-van Driel MM, Arnon J, Ornoy A, Clementi M, Di Gianantonio E, Koren G, Braunstein R, Berkovitch M. Pregnancy outcome of women exposed to azathioprine during pregnancy. Birth Defects Research A 2007; 79: 696-701.
  • Kallinich T, Haffner D, Niehues T, Huss K, Lainka E, Neudorf U, Schaefer C, Stojanov S, Timmann C, Keitzer R, Ozdogan H, Ozen S. Colchicine use in children and adolescents with Familial Mediterranean fever. Literature review and consensus statement. Pediatrics 2007; 119: e474-83.
  • Schaefer C. Off-label-Use von Medikamenten in der Schwangerschaft. Der Frauenarzt 2007; 48: 20-5.
  • Meister R, Schaefer C. Spontaneous abortion rates: Unbiased statistical estimation – with coumarins as an example (Abstract). Reprod Toxicol 2007; 24: 64.

2006 und älter (Auswahl)